Involvement of ventrolateral orbital cortex 5-HT 1-7 receptors in 5-HT induced depression of spared nerve injury allodynia

Neuroscience

Volumn 238, Issue , 2013, Pages 252-257

  Xu, W J ^a   Zhao, Y ^a   Huo, F Q ^a   Du, J Q ^a   Tang, J S ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

5 HT receptor subtypes; 5 hydroxytryptamine; Allodynia; Neuropathic pain; Pain modulation.; Ventrolateral orbital cortex

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; CYPROHEPTADINE; GRANISETRON; SB 258585; SB 699551; SEROTONIN 1 RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 5 RECEPTOR; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM DEPRESSION; CONTROLLED STUDY; MALE; MICROINJECTION; NERVE INJURY; NEUROMODULATION; NONHUMAN; ORBITAL CORTEX; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

ANIMALS; FRONTAL LOBE; HYPERALGESIA; MALE; NEURALGIA; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 84875843754     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.02.036     Document Type: Article

References (51)

1. Arsenault A., Sawynok J. Per surgical amitriptyline produces a preventive effect on afferent hypersensitivity following spared nerve injury. Pain 2009, 146:308-314.
2. Bard J.A., Zgombick J., Adham N., Vaysse P., Branchek T.A., Weinshank R.L. Cloning of a novel human serotonin receptor 5-HT7 positively linked to adenylate cyclase. J Biol Chem 1993, 268:23422-23426.
3. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38:1083-1152.
4. Blondel O., Vandecasteele G., Gastineau M., Leclerc S., Dahmoune Y., Langlois M., Fischmeister R. Molecular and functional characterization of a 5-HT4 receptor cloned from human atrium. FEBS Lett 1997, 412:465-474.
5. Cardenas C.G., Mar L.P., Vysokanov A.V., Arnold P.B., Cardenas L.M., Surmeier D.J., Scroggs R.S. Serotonergic modulation of hyperpolarization-activated current in acutely isolated rat dorsal root ganglion neurons. J Physiol 1999, 518:507-523.
6. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53:55-63.
7. Dang Y.H., Zhao Y., Xing B., Zhao X.J., Huo F.Q., Tang J.S., Qu C.L., Chen T. The role of dopamine receptors in ventrolateral orbital cortex-evoked anti-nociception in a rat model of neuropathic pain. Neuroscience 2010, 169(4):1872-1880.
8. Decosterd I., Woolf C.J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 2000, 87:149-158.
9. Derkach V., Surprenant A., North R.A. 5-HT3 receptors are membrane ion channels. Nature 1989, 339:706-709.
10. Dixon W.J. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980, 20:441-462.
11. Eglen R.M., Wong E.H.F., Dumuis A., Bockaert J. Central 5-HT4 receptors. Trends Pharmacol Sci 1995, 16:391-398.
12. Gale J.D., Grossman C.J., Whitehead J.W., Oxford A.W., Bunce K.T., Humphrey P.P. GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor. Br J Pharmacol 1994, 111:332-338.
13. Godinez-Chaparro B., Lopez-Santillan F.J., Orduna P., Granados-Soto V. Secondary mechanical allodynia and hyperalgesia depend on descending facilitation mediated by spinal 5-HT(4), 5-HT(6) and 5-HT(7) receptors. Neuroscience 2012, 222:379-391.
14. Goodfellow N.M., Bailey C.D., Lambe E.K. The native serotonin 5-HT(5A) receptor: electrophysiological characterization in rodent cortex and 5-HT(1A)-mediated compensatory plasticity in the knock-out mouse. J Neurosci 2012, 32:5804-5809.
15. Grailhe R., Grabtree G.W., Hen R. Human 5-HT5 receptors: the 5-HT5A receptor is functional but the 5-HT5B receptor was lost during mammalian evolution. Eur J Pharmacol 2001, 418:157-167.
16. Hannon J., Hoyer D. Molecular biology of 5-HT receptors. Behav Brain Res 2008, 195:198-213.
17. Hasuo H., Matsuoka T., Akasu T. Activation of presynaptic 5-hydroxytryptamine 2A receptors facilitates excitatory synaptic transmission via protein kinase C in the dorsolateral septal nucleus. J Neurosci 2002, 22:7509-7517.
18. Heinl C., Drdla-Schutting R., Xanthos D.N., Sandkuhler J. Distinct mechanisms underlying pronociceptive effects of opioids. J Neurosci 2011, 31:16748-16756.
19. Huo F.Q., Qu C.L., Li Y.Q., Tang J.S., Jia H. GABAergic modulation is involved in the ventrolateral orbital cortex 5-HT1A receptor activation-induced antinociception in the rat. Pain 2008, 139:398-405.
20. Huo F.Q., Chen T., Lv B.C., Wang J., Zhang T., Qu C.L., Li Y.Q., Tang J.S. Synaptic connections between GABAergic elements and serotonergic terminals or projecting neurons in the ventrolateral orbital cortex. Cereb Cortex 2009, 19:1263-1272.
21. Huo F.Q., Huang F.S., Lv B.C., Chen T., Feng J., Qu C.L., Tang J.S., Li Y.Q. Activation of serotonin 1A receptors in ventrolateral orbital cortex depresses persistent nociception: a presynaptic inhibition mechanism. Neurochem Int 2010, 57:749-755.
22. Kassai F., Schlumberger C., Kedves R., Pietraszek M., Jatzke C., Lendvai B., Gyertyan I., Danysz W. Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression. Behav Pharmacol 2012, 23:397-406.
23. Kilpatrick G.J., Jones B.J., Tyers M.B. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 1987, 330:746-748.
24. Kinsey A.M., Wainwright A., Heavens R., Sirinathsinghji D.J.S., Oliver K.R. Distribution of 5-ht5A, 5-ht5B, 5-ht6 and 5-HT7 receptor mRNAs in the rat brain. Brain Res Mol Brain Res 2001, 88:194-198.
25. Liu M., Zhou L., Chen Z., Hu C. Analgesic effect of iridoid glycosides from Paederia scandens (LOUR.) MERRILL (Rubiaceae) on spared nerve injury rat model of neuropathic pain. Pharmacol Biochem Behav 2012, 102:465-470.
26. Millan M.J. Descending control of pain. Prog Neurobiol 2002, 66:355-474.
27. Monti J.M., Leopoldo M., Jantos H. The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat. Behav Brain Res 2008, 191(2):184-189.
28. Neuman R.S., Zebrowska G. Serotonin (5-HT2) receptor mediated enhancement of cortical unit activity. Can J Physiol Pharmacol 1992, 70:1604-1609.
29. Ohno Y., Imaki J., Mae Y., Takahashi T., Tatara A. Serotonergic modulation of extrapyramidal motor disorders in mice and rats: role of striatal 5-HT3 and 5-HT6 receptors. Neuropharmacology 2011, 60(2-3):201-208.
30. Pasqualetti M., Ori M., Nardi I., Castagna M., Cassano G.B., Marazziti D. Distribution of the 5-HT5A serotonin receptor mRNA in the human brain. Brain Res Mol Brain Res 1998, 56:1-8.
31. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, Sydney. second ed.
32. Pertovaara A. Plasticity in descending pain modulatory systems. Prog Brain Res 2000, 129:231-242.
33. Pozzi L., Trabace L., Invernizzi R., Samanin R. Intranigral GR-113808, a selective 5-HT4 receptor antagonist, attenuates morphine-stimulated dopamine release in the rat striatum. Brain Res 1995, 692:265-268.
34. Qu C.L., Huo F.Q., Huang F.S., Li Y.Q., Tang J.S., Jia H. The role of 5-HT receptor subtypes in the ventrolateral orbital cortex of 5-HT-induced antinociception in the rat. Neuroscience 2008, 152:487-494.
35. Ren K., Dubner R. Descending modulation in persistent pain: an update. Pain 2002, 100:1-6.
36. Rydelek-Fitzgerald L., Teitler M., Fletcher P.W., Ismaiel A.M., Glennon R.A. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors. Brain Res 1990, 532:191-196.
37. Taiwo Y.O., Levine J.D. Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience 1992, 48:485-490.
38. Tang J.S., Qu C.L., Huo F.Q. The thalamic nucleus submedius and ventrolateral orbital cortex are involved in nociceptive modulation: a novel pain modulation pathway. Prog Neurobiol 2009, 89:383-389.
39. Thomas D.R. 5-ht5A receptors as a therapeutic target. Pharmacol Ther 2006, 111:707-714.
40. Thomas D.R., Larminie C.G., Lyons H.R., Fosberry A., Hill M.J., Hayes P.D. Cloning and pharmacological characterisation of the guinea pig 5-ht5A receptor. Eur J Pharmacol 2004, 494:91-99.
41. Vanegas H., Schaible H.G. Descending control of persistent pain: inhibitory or facilitatory?. Brain Res Rev 2004, 46:295-309.
42. Xu F.Y., Huo F.Q., Qu C.L., Tang J.S. 5-HT2A receptor involvement in mediating the ventrolateral orbital cortex-evoked anti-allodynia in a rat model of neuropathic pain: a presynaptic facilitatory effect. Acta Physiol Sin 2010, 62:252-253.
43. Yang Z., Liu X., Yin Y., Sun S., Deng X. Involvement of 5-HT(7) receptors in the pathogenesis of temporal lobe epilepsy. Eur J Pharmacol 2012, 685:52-58.
44. Zapata A., Pontis S., Schepers R.J., Wang R., Oh E., Stein A., Bäckman C.M., Worley P., Enguita M., Abad M.A., Trullas R., Shippenberg T.S. Alleviation of neuropathic pain hypersensitivity by inhibiting neuronal pentraxin 1 in the rostral ventromedial medulla. J Neurosci 2012, 32:12431-12436.
45. Zhang Y.Q., Tang J.S., Yuan B., Jia H. Inhibitory effects of electrical stimulation of thalamic nucleus submedius area on the rat tail flick reflex. Brain Res 1995, 696:205-212.
46. Zhang Y.Q., Tang J.S., Yuan B., Jia H. Inhibitory effects of electrically evoked activation of ventrolateral orbital cortex on the tail-flick reflex are mediated by periaqueductal gray in rats. Pain 1997, 72:127-135.
47. Zhang S., Tang J.S., Yuan B., Jia H. Involvement of the frontal ventrolateral orbital cortex in descending inhibition of nociception mediated by the periaqueductal gray. Neurosci Lett 1997, 224:142-146.
48. Zhang S., Tang J.S., Yuan B., Jia H. Inhibitory effects of electrical stimulation of ventrolateral orbital cortex on the rat jaw-opening reflex. Brain Res 1998, 823:359-366.
49. Zhang S., Tang J.S., Yuan B., Jia H. Inhibitory effects of glutamate-induced activation of thalamic nucleus submedius are mediated by ventrolateral orbital cortex and periaqueductal gray in rats. Eur J Pain 1998, 2:153-163.
50. Zhang S., Tang J.S., Yuan B., Jia H. Electrically-evoked inhibitory effects of the nucleus submedius on the jaw-opening reflex are mediated by ventrolateral orbital cortex and periaqueductal gray matter in the rat. Neuroscience 1999, 93:867-875.
51. Zimmermann M. Ethical guideline for investigation of experimental pain in conscious animals. Pain 1983, 16:109-110.